PubMed HealthSearch

Biomedical subjects

A Molinero

Publications and source records attributed to A Molinero.

At least 19 recordsLinked to original sources

Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice.

Injury to the central nervous system (CNS) elicits an inflammatory response involving activation of microglia, brain macrophages, and astrocytes, processes likely mediated by the release of proinflammatory cytokines. In order to determine the role of interleukin-6 (IL-6) during the inflammatory response in the brain following disruption of the blood-brain barrier (BBB), we examined the effects of a focal cryo injury to the fronto-parietal cortex in interleukin-6-deficient (IL-6-/-) and normal (IL-6+/+) mice. In IL-6+/+ mice, brain injury resulted in the appearance of brain macrophages and reactive astrocytes surrounding the lesion site. In addition, expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) and metallothionein-I+II (MT-I+II) were increased in these cells, while the brain-specific MT-III was only moderately upregulated. In IL-6-/- mice, however, the response of brain macrophages and reactive astrocytes was markedly depressed and the number of NSE positive neurons was reduced. Brain damage-induced GM-CSF and MT-I+II expression were also markedly depressed compared to IL-6+/+ mice. In contrast, MT-III immunoreactivity was markedly increased in brain macrophages and astrocytes. In situ hybridization analysis indicates that MT-I+II but not MT-III immunoreactivity reflect changes in the messenger levels. The number of cell divisions was similar in IL-6+/+ and IL-6-/- mice. The present results demonstrate that IL-6 is crucial for the recruitment of myelo-monocytes and activation of glial cells following brain injury with disrupted BBB. Furthermore, our results suggest IL-6 is important for neuroprotection and the induction of GM-CSF and MT expression. The opposing effect of IL-6 on MT-I+II and MT-III levels in the damaged brain suggests MT isoform-specific functions.

Animals

Effect of nitric oxide synthesis inhibition on mouse liver and brain metallothionein expression.

The role of nitric oxide (NO) production on metallothionein (MT) regulation in the liver and the brain has been studied in mice by means of the administration of nitric oxide synthase (NOS) inhibitors. Mice injected with either the arginine analog NG-monomethyl-L-arginine (L-NMMA) or the heme binding compound 7-nitro indazole (7-NI) showed consistently increased liver MT-I mRNA and MT-I + II total protein levels, suggesting that NO is involved in the hepatic MT regulation. In agreement with the liver results, in situ hybridization analysis demonstrated a significant upregulation of the brain MT-I isoform in areas such as the cerebrum cortex, neuronal CA1-CA3 layers and dentate gyrus of the hippocampus, and Purkinje cell layer of the cerebellum, in 7-NI treated mice. The same trend was observed for the brain specific isoform, MT-III, but to a much lower extent. The effect of NOS inhibition was also evaluated in a MT-inducing condition, namely during immobilization stress. In both the liver and the brain, stress upregulated the MT-I isoform, and 7-NI significantly reduced or even blunted the MT-I response to stress, suggesting a mediating role of NO on MT-I regulation during stress. Stress also increased the MT-III mRNA levels in some brain areas, an effect blunted by the concomitant administration of 7-NI, which in some areas even decreased MT-III mRNA levels below the saline injected mice. Results in primary culture of neurons and astrocytes demonstrate significant effects of the NOS inhibitors in some experimental conditions. The present results suggest that NO may have some role on MT regulation in both the liver and the brain.

Animals

Transgenic expression of interleukin 6 in the central nervous system regulates brain metallothionein-I and -III expression in mice.

The metallothionein (MT) gene family consists of several members (MT-I-IV) that are tightly regulated during development. MT-I and MT-II are expressed in many tissues, including the brain, whereas MT-III is expressed mainly in the central nervous system. However, the physiological roles of these isoforms in the brain and their regulation are poorly characterized. In this report, we have studied the putative role of IL-6 in the regulation of brain MT. The present results demonstrated that transgenic mice expressing IL-6 under the regulatory control of the glial fibrillary acidic protein gene promoter (GFAP-IL6 mice), and which develop chronic progressive neurodegenerative disease, show significantly increased MT-I + II protein levels in specific brain areas. Thus, the MT-I + II levels of 1- and 3-month-old GFAP-IL6 mice (G16 and/or G36 lines) were not altered in hippocampus but they were elevated in the cerebellum (highest induction), medulla plus pons, hypothalamus and remaining brain (lowest induction). The effect of the transgenic expression of IL-6 was more dramatic for MT-I + II protein than for MT-I mRNA levels, with the latter only marginally elevated in the G16 line at 3 months but not at 6 months of age where there was a tendency to decreased levels. Brain MT-I mRNA levels also tended to decrease in the higher expressor G36 line in 3-month-old mice despite the strongly elevated MT-I + II protein levels at this age. Therefore, in addition to increasing MT gene transcription, these results suggest a post-transcriptional effect of IL-6 or of a IL-6-dependent factor, in this chronic situation. The up-regulated brain MT-I + II protein levels in the GFAP-IL6 mice was comparable to the expression of the acute-phase response gene EB22/5, suggesting that these MT isoforms could be considered acute-phase response proteins in the brain. Brain MT-III mRNA levels followed a somewhat similar pattern that those of MT-I mRNA but the decreasing effect of IL-6 transgene production with age was more dramatic for the former, suggesting differential regulation of these MT isoforms by IL-6. The results indicate that these transgenic mice might be a valuable tool for further examining the role of the MT isoforms in brain physiology and pathobiology.

Animals

Role of Glucocorticoids on Rat Brain Metallothionein-I and -III Response to Stress.

The metallothionein (MT) gene family consists of four members (MT-I through -IV) that are tightly regulated during development. Whereas MT-I and MT-II are widely expressed isoforms, MT-III has been found to be mainly expressed in the central nervous system in adult animals, and is the only isoform that inhibits survival and neurite formation of cortical neurons in vitro. A number of models of brain injury have been shown to affect MT-III mRNA levels, which has been suggested to be related to the putative neurotrophic role of this protein. However, a stress response will presumably be associated to the brain injury which could, in turn, drive MT-III regulation. In the present report the effect of a classical stress model, immobilization stress, on brain MT regulation has been studied in rats. MT-I+II protein levels were measured by radioimmunoassay in up to eight brain areas and, as expected, it was found that stress increased selectively MT-I+II levels. Adrenalectomy (ADX) had a general decreasing effect on basal MT-I+II levels; however, ADX blunted the MT-I+II response to stress in cerebellum and presumably in frontal cortex and medulla plus pons but not in the hypothalamus. MT-I mRNA measurements were in accordance with the MT-I+II protein levels in the brain areas studied. In contrast to MT-I mRNA, MT-III mRNA levels of brain cortex tended to decrease during stress, although this effect was not statistically significant. ADX also tended to decrease basal MT-III mRNA levels. Northern blot assays of pooled mRNAs suggested similar differential regulation of these two brain MT isoforms in the cerebellum. These results indicate that glucocorticoids mediate brain MT-I+II response to stress in some but not all brain areas, that a role of these hormones is likely also for MT-III, and that the regulation of MT isoforms differs substantially in the brain.

Journal Article

Crowding stress induces changes in serum haemolytic and agglutinating activity in the gilthead sea bream Sparus aurata.

Sea bream Sparus aurata were subjected to crowding for 3 weeks and the levels of plasma cortisol and glucose were determined in order to ascertain the occurrence of stress. At the same time, selected indicators of the immune response were monitored through blood lymphocyte counting and selected humoral responses such as the haemagglutination activity (HA) of serum towards rabbit erythrocytes (RaRBC) and the alternative complement pathway (ACP) levels. The results show an initial moderate increase in cortisol followed by hyperglycaemia and recovery to basal levels. A pattern of immunodepression was detected afterwards as shown by decreases in ACP levels after 5 days and haemagglutination titre and circulating lymphocytes after 9 days. Nevertheless, ACP levels showed a significant increase after 9 days, and HA titres and circulating lymphocyte numbers also increased after 15 days. Normal values were recovered after 15 days for lymphocytes and ACP and 21 days for agglutination. Results are discussed in view of the incidence of stress on indicative parameters of endocrine and immune systems.

Agglutination

Railway track-like dermatitis: an atypical Mondor's disease?

The cases of two patients with linear, cordlike lesions on the anterolateral chest wall are reported. Both cases suggested a clinical diagnosis of Mondor's disease (i.e., sclerosing periphlebitis of the chest wall) with atypical aspects. The histologic picture showed a diffuse dermal infiltrate, predominantly of eosinophils mixed with lymphocytes and histiocytes, with some evidence of collagen degeneration. No flame figures were seen. Problems of differential diagnosis are discussed.

Axilla

Parakeratotic horns in a patient with Crohn's disease.

Horny finger-like lesions can be observed in many dermatoses. In some cases the clinical features suggest the diagnosis, but only the histological examination will confirm it. Our purpose here is to describe a case of multiple parakeratotic horns occurring in a patient with Crohn's disease.

Adult

[Eccrine angiomatous nevus].

A case of eccrine angiomatous nevus of the leg in a 21 year-old woman is reported. The lesion present since birth was painful on pressure and exhibited hyperhidrosis. Histological examination of the lesion showed an increased number of eccrine structures without structural abnormalities with an angiomatous vascular component. In addition, there were some neural sheets. Problems of differential diagnosis and histogenesis of the eccrine angiomatous hamartoma are discussed.

Adult

Basal cell carcinoma with matrical differentiation. Matrical carcinoma.

Three unusual cases of basal cell carcinoma showing matrical differentiation as evidenced by the focal presence of "shadow cells" within basaloid islands are described. The term basal cell tumor with matrical differentiation seems to be appropriate for this type of tumor. Its differentiation from other tumors, particularly malignant pilomatricoma, is also discussed.

Aged

White sponge nevus with epidermolytic changes.

A 42-year-old man with extensive white spongy lesions of the oral mucosa from childhood is reported. Histologic examination of two punch biopsies revealed many foci of epidermolytic hyperkeratosis. Similar lesions were present in one of his two brothers but he refused the biopsy. The problems of differential diagnosis are discussed.

Adult

[Nevus sebaceous].

Explore the source record for details and available documents.

Dermatitis, Seborrheic

Nevus comedonicus with epidermolytic hyperkeratosis.

A 7-year-old girl had a linear nevus comedonicus affecting the right upper limb. Histologic examination of two biopsies specimens showed both the common changes of nevus comedonicus and the presence of epidermolytic hyperkeratosis. Therefore, nevus comedonicus should be included in the list of dermatoses having the distinctive histologic pattern of epidermolytic hyperkeratosis.

Child